Upper limb motor dysfunction after intracerebral hemorrhage
Conditions
Interventions
taVNS Group:A portable transcutaneous nerve stimulation device was adopted, with electrodes placed in the left auricular concha area. The stimulation parameters were set as follows: frequency at 25 Hz
Sham Stimulation Group:An identical device with the same appearance and operation mode as that used in the intervention group was applied, with electrodes placed on the earlobes and the current intens
Sponsors
Deqing County People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 75 years old; 2. First-ever intracerebral hemorrhage confirmed by cranial computed tomography (CT) or magnetic resonance imaging (MRI); 3. Unilateral hemiplegia complicated with upper limb motor dysfunction, with a Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score ranging from 20 to 50; 4. Signed informed consent obtained from the patient or their legal representative.
Exclusion criteria
Exclusion criteria: 1. Comorbid with other neurological disorders that may impair motor function; 2. Severe cognitive impairment or aphasia, rendering the subject unable to cooperate with assessments and treatment; 3. Contraindications to transcutaneous auricular vagus nerve stimulation (taVNS), including local ear diseases or injuries, severe cardiovascular diseases, or implanted medical devices; 4. Pregnant or lactating women; 5. High risk of bleeding or abnormal coagulation function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Fugl-Meyer Assessment of Upper Extremity (FMA-UE) score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brunnstrom Recovery Stages (BRS);Modified Barthel Index (MBI);Incidence of adverse events; | — |
Countries
China
Contacts
Public ContactWang Yunhui
Neurosurgery Department, Deqing County People's Hospital
Outcome results
None listed